Daniel C. McFarland, DO

home / authors / daniel-c-mcfarland-do

Dr McFarland is an oncologist who also works in the field of consult-liaison psychiatry at Northwell Health/Lenox Hill Hospital, in New York, NY.

Articles

Serotonin Reuptake Inhibitor and Bleeding Risk, Part 2: Gastrointestinal (GI) Bleeding, Malignancy, Pregnancy, and Surgical Considerations

Gregg A. Robbins-Welty, MD, MS;Andrew N. Tuck, MD;Dale Marchant, FRANZCP;Andrew Gleason, FRANZCP;Richard Garrett Key, MD;Barbara Lubrano Di Ciccone, MD;Deepti A. Chopra, MBBS;Mona Mojtahedzadeh, MD;Fíona Fonseca, MD;Hermioni Lokko Amonoo, MD;Andrea DeSimone, DO;Daniel C. McFarland, DO

October 27th 2023

In this CME article, review literature on SRI-related bleeding complications in patients with GI bleeding, malignancy, perioperative settings, pregnancy, and hormonal therapy.

Bleeding Risk With SSRIs, Part 1: Cardiovascular and Cerebrovascular Considerations

September 26th 2023

In this CME article, get a better understanding of bleeding risk associated with use of serotonin reuptake inhibitors (SRIs) and review research-informed literature on related bleeding complications in patients with cardiovascular and cerebrovascular disease.

A Simple Concept With Complex Implications

Daniel C. McFarland, DO;Luigi Grassi, MD;Michelle Riba, MD, MS, DFAPA, FAPM

February 23rd 2022

Comorbidity: The concept is simple enough, but in practice, comorbidity drives complexity and presents the specters of diagnostic ambiguity and therapeutic unpredictability.